HBIO
HBIO
NASDAQ · Life Sciences Tools & Services

Harvard Bioscience Inc

$0.50
+0.02 (+4.92%)
As of Feb 8, 2:24 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 6.43M 6.41M 5.41M
Net Income 761.5K 780.8K 611.3K
EPS
Profit Margin 11.8% 12.2% 11.3%
Rev Growth -0.6% -3.7% -0.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.74M 1.63M 1.53M
Total Equity 15.11M 13.87M 13.47M
D/E Ratio 0.11 0.12 0.11
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.44M 1.44M 1.03M
Free Cash Flow 1.10M 1.10M 719.6K